JCP Weekly

depression

ASCP Corner

Diets and Disorders: Can Foods or Fasting Be Considered Psychopharmacologic Therapies?

J Clin Psychiatry 2020;81(1):19ac12727

ASCP Corner

Anti-Inflammatory Treatments for Major Depressive Disorder: What’s on the Horizon?

J Clin Psychiatry 2019;80(6):18ac12630

ASCP Corner

Medical Marijuana: What Physicians Need to Know

J Clin Psychiatry 2019;80(5):18ac12537

ASCP Corner

Are There Effective Psychopharmacologic Treatments for PTSD?

J Clin Psychiatry 2019;80(3):18ac12473

ASCP Corner

Inaccurate Prescribing Warnings in Electronic Medical Record Systems: Results From an American Society of Clinical Psychopharmacology Membership Survey

J Clin Psychiatry 2019;80(2):18ac12536

ASCP Corner

When Further Pharmacotherapy Seems Futile

J Clin Psychiatry 2019;80(1):18ac12276

ASCP Corner

Psychiatric Disorders and Comorbid Cannabis Use: When Should We Be Concerned and What Can We Do About It?

J Clin Psychiatry 2018;79(6):18ac12268

ASCP Corner

Psychiatric Disorders and Comorbid Cannabis Use: How Common Is It and What Is the Clinical Impact?

J Clin Psychiatry 2018;79(5):18ac12267

ASCP Corner

Motivational Interviewing: Overcoming Disparities in Pharmacotherapy Engagement

J Clin Psychiatry 2018;79(3):18ac12150

ASCP Corner

A Note From the ASCP President

J Clin Psychiatry 2018;79(1):17ac12081

ASCP Corner

Depression With Mixed Features in Major Depressive Disorder: A New Diagnosis or There All Along?

J Clin Psychiatry 2018;79(2):17ac11974

ASCP Corner

Patients With Alcohol Use Disorder Co-Occurring With Depression and Anxiety Symptoms: Diagnostic and Treatment Initiation Recommendations

J Clin Psychiatry 2018;79(1):17ac11999

ASCP Corner

Management of New Onset Psychosis in the Postpartum Period

J Clin Psychiatry 2017;78(9):1423–1424

ASCP Corner

Do You Order Pharmacogenetic Testing? Why?

J Clin Psychiatry 2017;78(8):1155–1156

ASCP Corner

Duration and Relevance of Untreated Psychiatric Disorders, 2: Nonpsychotic Psychiatric Disorders and Substance Use Disorders

J Clin Psychiatry 2017;78(4):464–465

ASCP Corner

Duration and Relevance of Untreated Psychiatric Disorders, 1: Psychotic Disorders

J Clin Psychiatry 2017;78(3):358–359

ASCP Corner

Narrowing the Gaps Between What We Know and What We Do in Psychiatry

J Clin Psychiatry 2015;76(10):1366–1372

ASCP Corner

Recommendations for the Monitoring of Serum Concentrations of Antipsychotic Drugs in the Treatment of Schizophrenia

J Clin Psychiatry 2015;76(9):1249–1250

ASCP Corner

Improving the Practice of Clinical Psychopharmacotherapy: The Process of Long-Term Management for Patients and Caregivers

J Clin Psychiatry 2015;76(6):735–736

ASCP Corner

Bipolar Therapeutics Update 2014: A Tale of 3 Treatments

J Clin Psychiatry 2015;76(1):69–70

ASCP Corner

Updates and Trends in the Treatment of Major Depressive Disorder

J Clin Psychiatry 2014;75(12):1419–1421

ASCP Corner

Can We Bottle Psychosocial Treatments for Addiction? The Role of Oxytocin

J Clin Psychiatry 2014;75(9):1028–1029

ASCP Corner

Hoarding Disorder: More Than Just a Problem of Too Much Stuff

J Clin Psychiatry 2014;75(8):893–894

ASCP Corner

J Clin Psychiatry/Inflammatory Depression: A Trifecta of Trouble

J Clin Psychiatry 2014;75(6):663–664

ASCP Corner

ASCP Corner: The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches

J Clin Psychiatry 2014;75(3):285-287

ASCP Corner

ASCP Corner: The ASCP Annual Meeting (NCDEU): A History

J Clin Psychiatry 2014;75(2):180

ASCP Corner

ASCP Corner: The Role of Vitamin D in Depression: From a Curious Idea to a Therapeutic Option

J Clin Psychiatry 2013;74(11):1121-1122

ASCP Corner

ASCP Corner: Decision Making and Antipsychotic Medication Treatment for Youth With Autism Spectrum Disorders: Applying Guidelines in the Real World

J Clin Psychiatry 2013;74(10):1022-1024

ASCP Corner

ASCP Corner: Antidepressant Use in Pregnancy and Risk of Autism Spectrum Disorders: A Critical Examination of the Evidence

J Clin Psychiatry 2013;74(9):940-941

ASCP Corner

ASCP Corner: Pulsed Intravenous Administration of Scopolamine Produces Rapid Antidepressant Effects and Modest Side Effects

J Clin Psychiatry 2013;74(8):850-851

ASCP Corner

ASCP Corner: Changes in the Diagnostic Criteria for Autism in <em>DSM-5</em>: Controversies and Concerns

J Clin Psychiatry 2013;74(7):739-740

ASCP Corner

ASCP Corner: Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder Comorbidity in Children and Adolescents: Evidence-Based Approach to Diagnosis and Treatment

J Clin Psychiatry 2013;74(6):628-629

ASCP Corner

ASCP Corner: Current Status of Ketamine and Related Compounds for Depression

J Clin Psychiatry 2013;74(5):516-517

ASCP Corner

ASCP Corner: Lessons Learned From <span style="font-variant:small-caps;">d</span>-Cycloserine: The Promise and Limits of Drug Facilitation of Exposure Therapy

J Clin Psychiatry 2013;74(4):415-416

ASCP Corner

ASCP Corner: Reconsidering Chronic Hyponatremia in Psychosis

J Clin Psychiatry 2013;74(3):278-279

ASCP Corner

ASCP Corner: Monoamine Oxidase Inhibitors Revisited: What You Should Know

J Clin Psychiatry 2013;74(2):189-191

ASCP Corner

Cardiovascular Disease and Bipolar Disorder: Risk and Clinical Implications

J Clin Psychiatry 2012;73(12):1563-1565

ASCP Corner

ASCP Corner: Discordance Between Researchers and Patients in Defining Remission From Depression

J Clin Psychiatry 2012;73(9):1262-1263

Case Report

Risperidone-Induced Dislocation of the Temporomandibular Joint

J Clin Psychiatry 2012;73(2):176

ASCP Corner

ASCP Corner: Stepping Back to Step Forward: Lessons From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

J Clin Psychiatry 2011;72(10):1429-1431

ASCP Corner

ASCP Corner: Assessing the Adequacy of Past Antidepressant Trials: A Clinician’s Guide to the Antidepressant Treatment Response Questionnaire

J Clin Psychiatry 2011;72(8):1152-1154

ASCP Corner

ASCP Corner: Rediscovering Adverse Anticholinergic Effects

J Clin Psychiatry 2011;72(6):869-870

ASCP Corner

Number Needed to Treat: What It Is and What It Isn’t, and Why Every Clinician Should Know How to Calculate It

J Clin Psychiatry 2011;72(3):412-413

ASCP Corner

Omega-3 Fatty Acids and Depression: From Cellular Mechanisms to Clinical Care

J Clin Psychiatry 2011;72(2):258-259

ASCP Corner

New Antipsychotic Drugs: How Do Their Receptor-Binding Profiles Compare?

J Clin Psychiatry 2010;71(9):1243-1244

ASCP Corner

Bereavement, Complicated Grief, and <em>DSM</em>, Part 2: Complicated Grief

J Clin Psychiatry 2010;71(8):1097-1098

ASCP Corner

Bereavement, Complicated Grief, and <em>DSM</em>, Part 1: Depression

J Clin Psychiatry 2010;71(7):955-956

ASCP Corner

ASCP Corner: Therapeutic Drug Monitoring in Pregnant and Postpartum Women: Recommendations for SSRIs, Lamotrigine, and Lithium

J Clin Psychiatry 2010;71(5):649-650

Case Report

Tardive Dystonia Due to Aripiprazole Use in a Neuroleptic-Naive Patient

J Clin Psychiatry 2010;71(5):652-653 [letter]

ASCP Corner

Transcranial Magnetic Stimulation for Medication-Resistant Depression

J Clin Psychiatry 2010;71(4):502-503

ASCP Corner

How to Efficiently Maintain Your Own Electronic Resource Library

J Clin Psychiatry 2010;71(2):207-208

ASCP Corner

ASCP Corner: Reconceptualizing Medication Management: Implications for Training and Clinical Practice

J Clin Psychiatry 2009;70(12):1722-1723

ASCP Corner

Do Glutamatergic Agents Represent a New Class of Antidepressant Drugs? Part 2

J Clin Psychiatry 2009;70(11):1604-1605

ASCP Corner

Do Glutamatergic Agents Represent a New Class of Antidepressant Drugs? Part 1

J Clin Psychiatry 2009;70(10):1473-1474

ASCP Corner

ASCP Corner: Genetic Studies of Drug Response and Side Effects in the STAR*D Study, Part 2

J Clin Psychiatry 2009;70(9):1323-1325

Case Report

Activation Induced by High-Dose Ziprasidone: A Case Report

J Clin Psychiatry 2009;70(9):1326-1327 [letter]

ASCP Corner

Genetic Studies of Drug Response and Side Effects in the STAR*D Study, Part 1

J Clin Psychiatry 2009;70(8):1186-1187

ASCP Corner

ASCP Corner: Suicide Risk and Psychopharmacology: Assessment and Management of Acute and Chronic Risk Factors

J Clin Psychiatry 2009;70(7):1052-1053

ASCP Corner

ASCP Corner: Adding Lithium or Anticonvulsants to Antipsychotics for the Treatment of Schizophrenia: Useful Strategy or Exercise in Futility?

J Clin Psychiatry 2009;70(6):932-933

ASCP Corner

ASCP Corner: Second-Generation Antipsychotic-Associated Diabetes Mellitus and Diabetic Ketoacidosis: Mechanisms, Predictors, and Screening Need (ASCP Corner)

J Clin Psychiatry 2009;70(5):765-766

ASCP Corner

ASCP Corner: All Antipsychotics Are Equal, but Some Are More Equal Than Others

J Clin Psychiatry 2009;70(3):429-430

ASCP Corner

ASCP Corner: Breastfeeding and Antidepressants: Clinical Dilemmas and Expert Perspectives

J Clin Psychiatry 2009;70(2):291-292

ASCP Corner

ASCP Corner: Why Aren't MAOIs Used More Often?

J Clin Psychiatry 2009;70(1):139-140

ASCP Corner

ASCP Corner: Is the Problem of a High Placebo Response Unique to Antidepressant Trials?

J Clin Psychiatry 2008;69(12):1979-1980

ASCP Corner

Qualifications for Recertification: An Important but Evolving Set of Standards

J Clin Psychiatry 2008;69(11):1829-1830

ASCP Corner

ASCP Corner: The Search for Knowledge: Developing the American Psychiatric Association's Practice Guideline for Major Depressive Disorder

J Clin Psychiatry 2008;69(10):1658-1659

ASCP Corner

ASCP Corner: Are Nutritional Supplements Ready for Prime Time?

J Clin Psychiatry 2008;69(9):1497-1498

ASCP Corner

ASCP Corner: Are Antidepressants Effective? What’s a Clinician to Think?

J Clin Psychiatry 2008;69(6):1014-1015

ASCP Corner

ASCP Corner: Antipsychotic Polypharmacy, Part 2: Why Use 2 Antipsychotics When 1 Is Not Good Enough?

J Clin Psychiatry 2008;69(5):860-861

ASCP Corner

ASCP Corner: Antipsychotic Polypharmacy, Part 1: Shotgun Approach or Targeted Cotreatment?

J Clin Psychiatry 2008;69(4):674-675

ASCP Corner

ASCP Corner: What Constitutes Evidence-Based Pharmacotherapy for Bipolar Disorder? Part 2: Complex Presentations and Clinical Context

J Clin Psychiatry 2008;69(3):495-496

ASCP Corner

ASCP Corner: Balancing Risks: Dosing Strategies for Antidepressants Near the End of Pregnancy

J Clin Psychiatry 2008;69(2):323-324

ASCP Corner

ASCP Corner: State of the Society

J Clin Psychiatry 2008;69(1):160-161

ASCP Corner

ASCP Corner: What Constitutes Evidence-Based Pharmacotherapy for Bipolar Disorder? Part 1: First-Line Treatments

J Clin Psychiatry 2007;68(12):1982-1983

ASCP Corner

ASCP Corner: Teaching and Practicing Psychopharmacology

J Clin Psychiatry 2007;68(11):1807-1808

ASCP Corner

ASCP Corner: Worried Sick: Antidepressants, Stress, and Inflammation

J Clin Psychiatry 2007;68(10):1613-1614

ASCP Corner

ASCP Corner: Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 2: Methodological Considerations

J Clin Psychiatry 2007;68(9):1441-1442

ASCP Corner

ASCP Corner: Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 1: Challenges and Developments

J Clin Psychiatry 2007;68(8):1301-1302

ASCP Corner

ASCP Corner: Dual Dependency on Cocaine and Alcohol in Opiate Addicts: Treatment Options.

J Clin Psychiatry 2007;68(7):1142-1143

ASCP Corner

ASCP Corner: Pharmacoepidemiology: Recent Findings and Challenges for Child and Adolescent Psychopharmacology

J Clin Psychiatry 2007;68(6):966-967

ASCP Corner

ASCP Corner: Psychopharmacology in the Emergency Room

J Clin Psychiatry 2007;68(5):796-797

ASCP Corner

ASCP Corner: Psychopharmacologic Treatment Response of HIV-Infected Patients to Antipsychotic Medications

J Clin Psychiatry 2007;68(4):631-632

ASCP Corner

ASCP Corner: Choice of Antipsychotic in HIV-Infected Patients

J Clin Psychiatry 2007;68(3):479-480

ASCP Corner

ASCP Corner: The Psychopharmacology of Violence With Emphasis on Schizophrenia, Part 2: Long-Term Treatment

J Clin Psychiatry 2007;68(2):331-332

ASCP Corner

ASCP Corner: The Psychopharmacology of Violence With Emphasis on Schizophrenia, Part 1: Acute Treatment

J Clin Psychiatry 2007;68(1):163-164

ASCP Corner

ASCP Corner: Measurement-Based Psychiatry: Definitions of Response, Remission, Stability, and Relapse in Schizophrenia

J Clin Psychiatry 2006;67(11):1813-1814

ASCP Corner

ASCP Corner: Combining Pharmacotherapy With Psychotherapeutic Management: Guidelines for Integration

J Clin Psychiatry 2006;67(10):1645-1646

ASCP Corner

ASCP Corner: Buprenorphine: Reflections of an Addictions Psychiatrist

J Clin Psychiatry 2006;67(9):1466-1467

ASCP Corner

ASCP Corner: FDA Post-Marketing Safety Decisions

J Clin Psychiatry 2006;67(8):1305-1306

ASCP Corner

ASCP Corner: ASCP Administers 10th Certification Exam.

J Clin Psychiatry 2006;67(7):1152-1153

ASCP Corner

ASCP Corner: Female Sexual Dysfunctions: What Controversy?

J Clin Psychiatry 2006;67(6):991-992

ASCP Corner

ASCP Corner: Commentary on the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)

J Clin Psychiatry 2006;67(5):831-832

ASCP Corner

ASCP Corner: Novel Transdermal Delivery Formulation of the Monoamine Oxidase Inhibitor Selegiline Nearing Release for Treatment of Depression

J Clin Psychiatry 2006;67(4):674-672

ASCP Corner

ASCP Corner: Use of Atypical Antipsychotics: Observations From Clinical Practice

J Clin Psychiatry 2006;67(3):490-491

ASCP Corner

Complex Chemical Concoctions

J Clin Psychiatry 2006;67(2):322-323

ASCP Corner

ASCP Corner: Real-Life Switching Strategies With Second-Generation Antipsychotics

J Clin Psychiatry 2006;67(1):160-161

ASCP Corner

ASCP Corner: Real-Life Dosing With Second-Generation Antipsychotics

J Clin Psychiatry 2005;66(12):1610-1611

ASCP Corner

ASCP Corner: Sexual Function and Dysfunction During Treatment With Psychotropic Medications

J Clin Psychiatry 2005;66(11):1488-1489

ASCP Corner

ASCP Corner: Metabolic Side Effects of Second-Generation Antipsychotics in Children and Adolescents: A Different Story?

J Clin Psychiatry 2005;66(10):1331-1332

ASCP Corner

Gender Differences in Clinical Psychopharmacology

J Clin Psychiatry 2005;66(9):1191

ASCP Corner

Increased Risk of Cerebrovascular Adverse Events and Death in Elderly Demented Patients Treated With Atypical Antipsychotics: What's a Clinician to Do?

J Clin Psychiatry 2005;66(8):1071-1071

ASCP Corner

Challenges and Opportunities in Teaching Psychopharmacology During Residency Training

J Clin Psychiatry 2005;66(7):948-948

ASCP Corner

Cultural Competence in Clinical Psychopharmacology

J Clin Psychiatry 2005;66(6):799-799

ASCP Corner

Reading Reports of Clinical Trial Results

J Clin Psychiatry 2005;66(5):653-653